ArticleArchives of medical science : AMS2026
Antibody-mediated immune responses and inflammatory bowel disease: insights from genetic correlation and Mendelian randomization.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Observational studies suggest a complex relationship between infectious diseases and inflammatory bowel disease (IBD), yet the underlying mechanisms remain unclear. This study examined the genetic correlations and causal associations between antibody-mediated immune responses (targeting 46 infectious pathogens) and IBD, using linkage disequilibrium score regression (LDSC) and Mendelian randomization (MR) to inform early prevention and personalized treatment. Material and methods: Data from the UK Biobank (8,735 samples) were used to identify independent SNPs associated with antibody responses. IBD-related data from the GWAS Catalog included 2,515 ulcerative colitis (UC) cases and 482,083 controls, as well as 1,342 Crohn's disease (CD) cases and 455,006 controls. Validation was done using datasets from the International IBD Genetics Consortium (IIBDGC), including 6,968 UC and 5,956 CD cases. Genetic correlations were assessed using LDSC, and causal links were investigated through MR analysis, employing inverse-variance weighting (IVW) and sensitivity analyses. Results: Genetic correlations were found between antibody responses to specific pathogens and IBD. MR analysis revealed causal effects of antibody responses to four pathogens on UC and protective/risk effects on CD. No horizontal pleiotropy or heterogeneity was observed, and sensitivity analyses confirmed the consistency of the findings. Conclusions: This study provides genetic evidence for causal associations between antibody-mediated immune responses to 46 pathogens and IBD in European populations, offering insights into IBD pathogenesis and implications for prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.